These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 20609464

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.
    Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR, DeMatteo R, Poynor EA, Abu-Rustum NR, Barakat RR.
    Gynecol Oncol; 2004 Sep; 94(3):650-4. PubMed ID: 15350354
    [Abstract] [Full Text] [Related]

  • 3. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Zivanovic O, Eisenhauer EL, Zhou Q, Iasonos A, Sabbatini P, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS.
    Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
    [Abstract] [Full Text] [Related]

  • 4. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
    Chi DS, Zivanovic O, Palayekar MJ, Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Leitao MM, Brown CL, Barakat RR.
    Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience.
    Peiretti M, Zanagnolo V, Aletti GD, Bocciolone L, Colombo N, Landoni F, Minig L, Biffi R, Radice D, Maggioni A.
    Gynecol Oncol; 2010 Nov; 119(2):259-64. PubMed ID: 20800269
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
    Shih KK, Chi DS, Barakat RR, Leitao MM.
    Gynecol Oncol; 2010 Mar; 116(3):364-9. PubMed ID: 19897231
    [Abstract] [Full Text] [Related]

  • 9. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
    Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, Sonoda Y, Levine DA, Hensley M, Barakat RR.
    Gynecol Oncol; 2006 Nov; 103(2):559-64. PubMed ID: 16714056
    [Abstract] [Full Text] [Related]

  • 10. Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer.
    Bashir S, Gerardi MA, Giuntoli RL, Montes TP, Bristow RE.
    Gynecol Oncol; 2010 Nov; 119(2):255-8. PubMed ID: 20739051
    [Abstract] [Full Text] [Related]

  • 11. Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series.
    Shih KK, Chi DS, Barakat RR, Leitao MM.
    Gynecol Oncol; 2010 May; 117(2):330-5. PubMed ID: 20189234
    [Abstract] [Full Text] [Related]

  • 12. Total colectomy as part of primary cytoreductive surgery in advanced Müllerian cancer.
    Song YJ, Lim MC, Kang S, Seo SS, Park JW, Choi HS, Park SY.
    Gynecol Oncol; 2009 Aug; 114(2):183-7. PubMed ID: 19427682
    [Abstract] [Full Text] [Related]

  • 13. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.
    Black D, Iasonos A, Ahmed H, Chi DS, Barakat RR, Abu-Rustum NR.
    Gynecol Oncol; 2007 Oct; 107(1):66-70. PubMed ID: 17614125
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY.
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [Abstract] [Full Text] [Related]

  • 16. Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma.
    Ye S, He T, Liang S, Chen X, Wu X, Yang H, Xiang L.
    BMC Cancer; 2017 May 05; 17(1):317. PubMed ID: 28476108
    [Abstract] [Full Text] [Related]

  • 17. Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.
    Chi DS, Ramirez PT, Teitcher JB, Mironov S, Sarasohn DM, Iyer RB, Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Brown CL, Aghajanian C, Gershenson DM, Hoskins WJ, Hricak H, Barakat RR.
    J Clin Oncol; 2007 Nov 01; 25(31):4946-51. PubMed ID: 17971592
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.
    Bristow RE, Peiretti M, Zanagnolo V, Salani R, Giuntoli RL, Maggioni A.
    Gynecol Oncol; 2008 Jun 01; 109(3):364-9. PubMed ID: 18396322
    [Abstract] [Full Text] [Related]

  • 20. Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer.
    Tsolakidis D, Amant F, Van Gorp T, Leunen K, Neven P, Vergote I.
    Gynecol Oncol; 2010 Mar 01; 116(3):489-96. PubMed ID: 19954825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.